Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

183 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Resolving Resident Colonic Muscularis Macrophage Diversity and Plasticity During Colitis.
Ohishi K, Dora D, Han CY, Guyer RA, Ohkura T, Kazimierczyk S, Picard N, Leavitt AR, Ott LC, Rahman AA, Mueller JL, Shpigel NY, Jain N, Nagy N, Hotta R, Goldstein AM, Stavely R. Ohishi K, et al. Among authors: leavitt ar. Inflamm Bowel Dis. 2025 Jan 6;31(1):151-168. doi: 10.1093/ibd/izae155. Inflamm Bowel Dis. 2025. PMID: 39102823
Highly neurogenic glia from human and mouse myenteric ganglia generate functional neurons following culture and transplantation into the gut.
Mueller JL, Leavitt AR, Rahman AA, Han CY, Ott LC, Mahdavian NS, Carbone SE, King SK, Burns AJ, Poole DP, Hotta R, Goldstein AM, Stavely R. Mueller JL, et al. Among authors: leavitt ar. Cell Rep. 2024 Nov 26;43(11):114919. doi: 10.1016/j.celrep.2024.114919. Epub 2024 Oct 30. Cell Rep. 2024. PMID: 39471175 Free PMC article.
Structure-guided discovery of viral proteins that inhibit host immunity.
Yirmiya E, Hobbs SJ, Leavitt A, Osterman I, Avraham C, Hochhauser D, Madhala B, Skovorodka M, Tan JMJ, Toyoda HC, Chebotar I, Itkin M, Malitsky S, Amitai G, Kranzusch PJ, Sorek R. Yirmiya E, et al. Among authors: leavitt a. Cell. 2025 Jan 20:S0092-8674(24)01478-8. doi: 10.1016/j.cell.2024.12.035. Online ahead of print. Cell. 2025. PMID: 39855193
Efficacy, safety, and quality of life 4 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A in the phase 3 GENEr8-1 trial.
Leavitt AD, Mahlangu J, Raheja P, Symington E, Quon DV, Giermasz A, López Fernández MF, Kenet G, Lowe G, Key NS, Millar CM, Pipe SW, Madan B, Chou SC, Klamroth R, Mason J, Chambost H, Peyvandi F, Majerus E, Pepperell D, Rivat C, Yu H, Robinson TM, Ozelo MC. Leavitt AD, et al. Res Pract Thromb Haemost. 2024 Oct 30;8(8):102615. doi: 10.1016/j.rpth.2024.102615. eCollection 2024 Nov. Res Pract Thromb Haemost. 2024. PMID: 39687929 Free PMC article.
Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B.
Cuker A, Kavakli K, Frenzel L, Wang JD, Astermark J, Cerqueira MH, Iorio A, Katsarou-Fasouli O, Klamroth R, Shapiro AD, Hermans C, Ishiguro A, Leavitt AD, Oldenburg JB, Ozelo MC, Teitel J, Biondo F, Fang A, Fuiman J, McKay J, Sun P, Rasko JEJ, Rupon J; BENEGENE-2 Trial Investigators. Cuker A, et al. Among authors: leavitt ad. N Engl J Med. 2024 Sep 26;391(12):1108-1118. doi: 10.1056/NEJMoa2302982. N Engl J Med. 2024. PMID: 39321362 Clinical Trial.
183 results